Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol pharmacokinetics before and after Roux-en-Y gastric bypass
NL-OMON55190Phase 4Active, not recruiting
- Sponsor
- Albert Schweitzer Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acetaminophen in obesity, sponsored by Albert Schweitzer Hospital. Primary endpoints: Paracetamol pharmacokinetics after oral dosing and Paracetamol pharmacokinetics after oral and intravenous dosing in amendment subgroup. Started Feb 2020; status: active, not recruiting.
02
Drugs
acetaminophen
03
Conditions
obesity
Beyond the preview
Go deeper on NL-OMON55190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55190.